文献速递帕金森病与运动障碍

通往帕金森病预防之路:结论与展望

Path to Parkinson Disease Prevention: Conclusion and Outlook.
PubMed 文献 · Neurology · 2022-01-01

本文综述了帕金森病前驱期病理生理与临床表现的认识进展为早期干预提供的机遇,并基于帕金森病预防会议「规划帕金森病预防:试验设计研讨会与工作坊」的讨论,围绕纳入对象、干预内容、预防测量方式及前驱期启动时机四个关键试验设计问题,总结了帕金森病预防试验的主要机遇与挑战,指出尽管进展巨大,仍有若干问题需在预防试验筹划与落地过程中审慎考虑和解决。

要点

  • 帕金森病前驱期认识的进展为尽早干预以延缓或阻止进展为临床运动期帕金森病提供了独特机会。
  • 预防试验设计需回答纳入谁、测试什么、如何测量预防以及前驱期何时启动试验四个关键问题。
  • 尽管进展巨大,仍有若干问题需在预防试验筹划和成为现实的过程中审慎考虑与解决。

核心结论

  • 帕金森病前驱期认识的巨大进展为尽早开展治疗干预以延缓甚至阻止进展为临床运动期帕金森病提供了独特机会。
  • 预防试验设计需围绕纳入谁、测试什么、如何测量预防以及前驱期何时启动试验等关键问题展开。
  • 尽管已取得巨大进展,仍需承认若干问题有待在预防试验筹划与落地过程中审慎考虑和解决。

研究设计与样本

  • 本文为综述,基于帕金森病预防会议「规划帕金森病预防:试验设计研讨会与工作坊」的讨论,总结帕金森病预防试验设计的主要机遇与挑战。

主要发现

  • 综述按纳入谁、测试什么、如何测量预防及前驱期何时启动试验四个关键试验设计问题组织帕金森病预防试验的机遇与挑战。
  • 文章阐述了上述问题对负责任、可持续且富有成效的预防试验进一步规划的意义。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出,尽管已取得巨大进展,仍需承认若干问题有待在预防试验筹划与落地过程中审慎考虑和解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tremendous progress in our understanding of the pathophysiology and clinical manifestations of the prodromal phase of Parkinson disease (PD) offers a unique opportunity to start therapeutic interventions as early as possible to slow or even stop the progression to clinically manifest motor PD. A Parkinson's Prevention Conference, "Planning for Prevention of Parkinson's: A trial design symposium and workshop" was convened to discuss all issues that need to be addressed before the launch of the first PD prevention study. In this review, we summarize the major opportunities and challenges in designing prevention trials in PD, organized by the following critical trial design questions: Who (should be enrolled)? What (to test)? How (to measure prevention)? and the pivotal question, When during the prodromal disease (should we start these trials)? We outline the implications of these questions and their meaning for a responsible, sustainable, and fruitful further planning for prevention trials. Despite the great progress that has been made, it needs to be acknowledged that several queries remain to be carefully considered and addressed because prevention trials are being planned and become a reality.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Berg D, Crotty GF, Keavney JL, et al. Path to Parkinson Disease Prevention: Conclusion and Outlook. Neurology. 2022. PMID: 35970586. doi:10.1212/WNL.0000000000200793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。